Literature DB >> 33542935

Enhancing Catecholase Activity of a Recombinant Human Tyrosinase Through Multiple Strategies.

Arman Shahrisa1, Maryam Nikkhah2, Hadi Shirzad3, Roudabeh Behzadi4, Majid Sadeghizadeh1.   

Abstract

BACKGROUND: Tyrosinases are copper-containing enzymes that initiate the melanin synthesis. They catalyze the direct oxidation of L-tyrosine or L-DOPA into L-DOPAquinone.
OBJECTIVES: In present study, we aimed to obtain a recombinant tyrosinase with enhanced catecholase activity through site-directed mutagenesis.
MATERIALS AND METHODS: The coding sequence of human tyrosinase along with native signal sequence was cloned into pET-28a (+). BL-21 was used as expression host and recombinant protein was purified by Ni-NTA resins. Site-directed mutagenesis was performed on M374 residue to achieve four mutants: M374D, M374T, M374K and M374R. Chloride ions (Cl-) were removed from all solutions, and an extra amount of Cu2+ ions was added to recombinant tyrosinases by a novel technique during the purification process. Removal of Cl- ions and addition of extra Cu2+ ions tripled catecholase activity of the recombinant protein. Therefore, all mutants were obtained under similar conditions.
RESULTS: Although all the mutants presented higher catecholase activity in comparison to the wild-type enzyme, a significant increase in catecholase activity of the M374D mutant was observed ‒ 13.2-fold. In silico modeling suggested that a de novo hydrogen bond occurs between side chain carboxyl oxygens of D374 and H367 in M374D. In the wild-type tyrosinase, the peptide oxygen atom of M374 is responsible for hydrogen bonding with H367.
CONCLUSIONS: Our data suggests that M374D mutational variant has applications in different areas such as agriculture, industry, and medicine. Copyright:
© 2020 The Author(s); Published by Iranian Journal of Biotechnology.

Entities:  

Keywords:  Catecholase activity; E.coli, Recombinant human tyrosinase; Site-directed mutagenesis

Year:  2020        PMID: 33542935      PMCID: PMC7856396          DOI: 10.30498/IJB.2020.137293.2310

Source DB:  PubMed          Journal:  Iran J Biotechnol        ISSN: 1728-3043            Impact factor:   1.671


1. Background

Pigmentation of hair, skin, and eyes mainly depends on the quantity, quality, and distribution of melanin. In the sequential pathway of melanin formation, tyrosinase (EC 1.14.18.1) is the rate-limiting enzyme that initializes cascade reactions leading to the formation of melanin ( 1 , 2 ). Tyrosinases are melanocytic copper containing enzymes ( 1 , 3 ) that catalyze the direct oxidation of L-tyrosine (cresolase/monophenolase activity) or L-DOPA (catecholase/diphenolase activity) into L-DOPAquinone ( 2 , 4 ). L-DOPAquinone is a highly reactive intermediate and therefore undergoes non-enzymatic and enzymatic reactions to form eumelanin and pheomelanin through separate pathways. Melanin synthesis is performed within specialized membrane-bound organelles known as melanosomes, and then those melanosomes are transferred to surrounding epidermal cells called keratinocytes ( 1 , 5 ). Tyrosinases along with catechol oxidases in plants and hemocyanins (oxygen carrier proteins) in arthropods comprise type-3 copper protein family. According to crystallographic evidence, all type-3 copper proteins share similar binuclear active site structure in which six conserved histidine residues coordinate a pair of copper atoms (CuA and CuB). During the catalytic reaction, type 3 copper centers exist in three forms. The deoxy form is inactive state of enzyme which binds molecular oxygen to provide the oxy form. The oxy form is capable of performing both cresolase and catecholase activities of tyrosinase while met form is only capable of performing cresolase activity ( 2 , 6 , 7 ). Despite the structural information provided by crystallographic results, the exact mechanism of catalytic reactions was unclear until recently ( 8 ). Since tyrosinase is the initiating enzyme of melanogenesis pathway, any changes in coding region sequence, gene expression, protein folding, post-translational modifications or even in chemical environment of melanocytes can be associated with several disorders including malignant melanoma ( 9 - 11 ), oculocutaneous albinism 1 (OCA1) ( 12 , 13 ) and vitiligo ( 14 ). Production of human tyrosinase as a recombinant protein enables the researchers to further study the three-dimensional structure and catalytic mechanism of the enzyme and to find new tyrosinase inhibitors with fewer side effects. Moreover, the recombinant enzyme can be used in tyrosinase-based biosensors for measuring phenol content and other toxic compounds. Tyrosinases are helpful in detoxification of phenol-containing wastewater/soil, and synthesis of L-DOPA and Melanin. They are also useful in the production of cross-linked proteins ( 15 ), allowing biocatalysts such as lipase to be easily recycled.

2. Objectives

In the present study, we have produced recombinant human tyrosinase in Escherichia coli. This recombinant protein is produced in soluble form and can be readily purified by metal affinity chromatography. In addition, multiple strategies were considered to improve the catalytic activity of the recombinant protein including site-directed mutagenesis, addition of copper ions and removal of Cl ions.

3. Materials and Methods

3.1. Materials

T4 DNA ligase was purchased from Fermentas (Vilnius, Lithuania). Kanamycin, L-3,4-Dihydroxyphenylalanine (L-DOPA), and 30-kDa-cutoff dialysis membrane were obtained from Sigma-Aldrich (Shanghai, China). 3-Methyl-2-benzothiazolinon-hydrazon hydrochloride indicator (MBTH) was purchased from Merk (Darmstadt, Germany). 1kb DNA ladder and protein marker (precision plus protein dual color standards) were obtained from SolisBioDyne (Tartu, Estonia) and Bio-Rad (Marne La Coquette, France) respectively.

3.2. Cloning the Tyrosinase Coding Sequence into pET- 28a(+)

The complete coding sequence of human tyrosinase comprising native signal sequence was obtained from NCBI (NM_000372.4) and modified by the addition of EcoRI and HindIII restriction sites to 5′ and 3′ ends respectively (designated as hSTyr). hSTyr was synthesized in the pCR2.1 vector by EurofinsMWG/ Operon (Regensburg, Germany) The tyrosinase coding sequence was subcloned into the pET-28a(+) expression vector (Novagen, Madison, USA) between EcoRI and HindIII restriction sites. Chemically competent E. coli DH5α cells were transformed with the ligation products, and then the bacteria were cultured on the LB plate supplemented with50 μg.mL-1 kanamycin. Recombinant colonies harboring pET-hSTyr (pET- 28a(+) containing wild-type hSTyr) were identified by colony-PCR.

3.3. Site-Directed Mutagenesis

Site-directed mutagenesis was performed on pET-hSTyr according to QuikChange site-directed mutagenesis (Stratagene, La Jolla, USA) using four pairs of mutagenic primers. PCR conditions are as follows: one denaturation cycle at 94 ˚C for 1 min; 18 cycles of denaturation (94 ˚C, 30 sec), annealing (55 ˚C, 30 sec), and extension (68 ˚C, 14 min); plus a final extension cycle of 68 ˚C for 10 min. List of mutagenic primers has been shown in Table 1. PCR products were precipitated by ethanol and then treated by DpnI (Fermentas, Vilnius, Lithuania) to eliminate template pET-hSTyr constructs. pET-hSTyr constructs with desired mutations M374D, M374K, M374T and M374R were respectively designated as pET-hSTyr(D), pET-hSTyr(K), pET-hSTyr(T) and pET-hSTyr(R).
Table 1

List of mutagenic primers was used for QuikChange site-directed mutagenesis. Substituted nucleotides are indicated in lower case.

MutationForward primerReverse primer
M374D5´-CTATATGAATGGAACAgatTCCCAGGTAC-3´5´-GTACCTGGGAatcTGTTCCATTCATATAG-3´
M374T5´-CTATATGAATGGAACAacaTCCCAGGTAC-3´5´-GTACCTGGGAtgtTGTTCCATTCATATAG-3´
M374K5´-CTATATGAATGGAACAaaaTCCCAGGTAC-3´5´-GTACCTGGGAtttTGTTCCATTCATATAG-3´
M374R5´-CTATATGAATGGAACAcgtTCCCAGGTAC-3´5´-GTACCTGGGAgcaTGTTCCATTCATATA-3´
List of mutagenic primers was used for QuikChange site-directed mutagenesis. Substituted nucleotides are indicated in lower case.

3.4. Protein Expression and Purification

Chemically competent E.coli BL21 cells were transformed with pET-hSTyr constructs (designated as BL21/pET-hSTyr) and the pre-culture was prepared by introducing a colony into 5 mL modified LB broth (10 gr tryptone, 5 gr yeast extract, 2.31 gr KH2PO4, 12.54 gr KH2PO4 per liter) supplemented with 50 μg.mL-1 kanamycin. After 16 hours, 4 mL of each pre-culture was added to 400 mL fresh TB broth (4 mL glycerol, 12 gr tryptone, 24 gr yeast extract, 2.31 gr KH2PO4, 12.54 gr KH2PO4 per liter) supplemented with 50 μg.mL-1 kanamycin. Culture media were incubated at 37 ˚C while shaking until the OD600 reached to 0.6. Protein expression was induced by addition of 1 mM IPTG (Sigma-Aldrich, Germany) and then culture media was incubated at 18 ˚C for up to 16 hours with vigorous shaking. The cells were precipitated by spinning the cultures at 10,000 g for ten minutes at 4 °C. Bacterial pellets were resuspended in equal volume of binding buffer and sonicated on ice for 15 cycles of 20-second pulses with 40-second intervals. The lysate was spun for 20 minutes at 12,000 g to separate soluble and insoluble fractions. Protein expression was assessed by SDS-PAGE analysis on a 10% polyacrylamide gel as described by Laemmli ( 16 ). BL21 cells harboring pET-28a(+) (designated as BL21/pET-28a(+)) were utilized as negative control for protein expression. After evaluation of protein quality by 10% SDS-PAGE, the supernatant was transferred to Ni-NTA columns. Protein purification was performed under native conditions according to manufacturer’s instruction. Each sample was loaded onto a 10 mL purification column containing 1 mL of Ni–NTA resins (Novagen, Darmstadt, Germany). Resins were first washed with 20 mL wash buffer (50 mM NaH2PO4, pH 8.0; 300 mM (NH4)2SO4; 20 mM imidazole) supplemented with 100 μM CuSO4 and subsequently by 20 mL wash buffer lacking CuSO4 to remove free Cu2+ ions. Attached proteins were eluted by elution buffer (50 mM NaH2PO4, pH 8.0; 300 mM (NH4)2SO4; 250 mM imidazole) and then dialyzed overnight against phosphate buffer (25 mM NaH2PO4-Na2HPO4, pH 6.8; 10% v.v-1 of glycerol) at 4 ˚C. The protein concentration of each sample was determined by Bradford assay ( 17 ).

3.5. Measurement of the Catecholase Activity

The catecholase activity of each tyrosinase variant was measured according to a previously described method ( 18 ) with minor modifications. The reaction mixture (total volume 1.0 mL) was prepared by mixing 410 μL assay buffer (120 mM sodium phosphate pH 7.1, 5% v.v- 1 of N,N’-dimethyl formamide), 200 μL of 5 mM L-dopa, 290 μL of 20.7 mM MBTH to yield final concentrations of 50 mM sodium phosphate, 2% (by vol.) N,N’-dimethyl formamide, 1 mM L-dopa, 6 mM MBTH, and final pH of 6.9. The reaction mixture was incubated at 37 °C for 10 minutes. At the same time, purified tyrosinase was transferred from -20 ˚C to room temperature. Following the addition of tyrosinase to the reaction mixture and pipetting, the increase in absorbance at 505 nm was monitored (UV S-2100, Scinco, Korea) over a period of 10 minutes. The specific activity of each tyrosinase variant was expressed as means ± SD (standard deviation), and statistical differences were evaluated by ANOVA followed by Tukey’s HSD (post-hoc test). P<0.05 was considered statistically significant.

3.6. In silico Analysis

In order to evaluate the effect of site-directed mutagenesis on the structure of recombinant human tyrosinase, required three-dimensional models were prepared by I-TASSER suite 4.1 ( 19 ). The full-length amino acid sequence of human tyrosinase along with attached N-terminal tags was given to I-TASSER suite. For each mutational variant, input sequence was altered to include the desired mutation. Obtained models were analyzed according to both C-score and evaluation results from SAVES ( 20 - 22 ) and PROSESS ( 23 ) metaservers. Superimposition and visualization of models were performed by UCSF Chimera v1.9 (24)

4. Results

4.1. Construction of pET-hSTyr, pET-hSTyr(D), pET-hSTyr(K), pET-hSTyr(T) and pET-hSTyr(R)

All pET-hSTyr (Fig. 1) vectors were verified by colony- PCR, double digestion by EcoRI and HindIII (Fig.2) and sequence analysis using universal and specific primers (Supplementary data 1). Sequencing results confirmed the presence of desired mutations without any additional mutation. Figure 3 shows the structure of a transcript encoded by a pET-hSTyr construct.
Figure 1

The Map of the pET-hSTyr expression vector.

Figure 2

Double digestions of three pET-hSTyr constructs. M represents the DNA marker. 1 shows the intact pET-hSTyr construct while 2 shows the same construct after double digestion by EcoRI and HindIII. 3 and 4 represent intact construct and double digestion results for pET-hSTyr(D) respectively. 5 and 6 correspond to pET-hSTyr(T) construct and its double digestion result respectively.

Figure 3

Schematic representation of full transcript which is coded by a pET-hSTyr construct. Each green segment represents a contiguous exon in a genomic region. 6x His-tag sequence adjacent to 3´ end is not translated due to the presence of native termination codon in tyrosinase sequence.

The Map of the pET-hSTyr expression vector. Double digestions of three pET-hSTyr constructs. M represents the DNA marker. 1 shows the intact pET-hSTyr construct while 2 shows the same construct after double digestion by EcoRI and HindIII. 3 and 4 represent intact construct and double digestion results for pET-hSTyr(D) respectively. 5 and 6 correspond to pET-hSTyr(T) construct and its double digestion result respectively. Schematic representation of full transcript which is coded by a pET-hSTyr construct. Each green segment represents a contiguous exon in a genomic region. 6x His-tag sequence adjacent to 3´ end is not translated due to the presence of native termination codon in tyrosinase sequence.

4.2. Protein Expression and Purification of Tyrosinases

Protein expression and purification were done as mentioned in material and methods. Purified enzymes were evaluated by 10% SDS-PAGE analysis, and then, the SDS-PAGE was assessed by TotalLab Quant software to determine the molecular weight of the purified tyrosinase. Unexpectedly, two adjacent bands with a molecular weight of 68 kDa and 65 kDa were visible on SDS-PAGE gel. (Fig.4). Since bacterial pellet was lysed in binding buffer supplemented with PMSF and all the procedures on the cell lysis were carried out using ice cold buffers, shorter isoform could be the result of the protease activity in the host cells.
Figure 4

Purified wild-type tyrosinase. Purified tyrosinase consisted of two bands of 68 and 65 kDa. The former is the full-length enzyme, and the latter is formed probably due to slight proteolysis on the full-length isoform.

4.3. Effect of Copper and Chloride Ions on the Catecholase Activity

Since, Clˉ ions are reversible tyrosinase inhibitors and can fully inactivate tyrosinase at a concentration of 800 mM ( 25 - 27 ), LB media was prepared with phosphate buffer instead of NaCl and TB media was chosen for protein expression since it lacks NaCl. Furthermore, Ni- NTA buffers were prepared with (NH4)2SO4 rather than NaCl. On the other hand, it has long been known that presence of additional Cu2+ ions can enhance the activity of tyrosinases, but the reason is still unknown ( 28 ). In this study, Cu2+ ions were added to the recombinant proteins during the purification process, and the excess amount of copper ionswas removed by subsequent resin washes. To examine the effect of additional Cu2+ ions on catecholase activity of the wild-type tyrosinase, half of the Ni-NTA resins with attached tyrosinase were transferred to another column. One column of resin-bound tyrosinases washed with normal washing buffer (designated as PSTyr), while the other column was first washed with the modified washing buffer supplemented with Cu2+ ions and then with normal washing buffer to remove free Cu2+ ions (designated as PSTyr-Cu2+). Removal of free Cu2+ ions allows investigating the effect of attached Cu2+ ions. After protein purification and dialysis, PSTyr-Cu2+ exhibited a three-fold increase in the catecholase activity in comparison to PSTyr. Therefore, mutational variants were purified under similar conditions as described for PSTyr-Cu2+. Purified wild-type tyrosinase. Purified tyrosinase consisted of two bands of 68 and 65 kDa. The former is the full-length enzyme, and the latter is formed probably due to slight proteolysis on the full-length isoform.

4.4. Effects of Site-Directed Mutagenesis on the Catecholase Activity

M374D mutational variant (designated as M374D-PSTyr-Cu2+) exhibited a statistically significant 4.4-fold increase in the catecholase activity regarding PSTyr- Cu2+ (overall 13.2-fold increase regarding PSTyr). The differences in catecholase activity of the other mutational variants were not statistically significant. However, their catecholase activities were also higher than PSTyr-Cu2+. M374T mutational variant (designated as M374T-PSTyr-Cu2+) exhibited a two-fold increase in the catecholase activity as compared to PSTyr-Cu2+ (overall 6.1-fold increase comparing to PSTyr). The activities of two other mutational variants, M374K and M374R (respectively designated as M374K-PSTyr- Cu2+ and M374R-PSTyr-Cu2+), were comparable with PSTyr-Cu2+. The specific activities of all tyrosinase variants havebeen shown in Table 2.
Table 2

The measured specific activity of the different tyrosinase variants by MBTH assay. Catecholase activity of each variant was measured three times, and the mean value of measurements was used.

SampleSpecific activity (mmol min-1 mg-1) ± S.E.
PSTyr5.89 ± 0.5
PSTyr-Cu2+17.72 ± 0.3
PSTyr(M374D)-Cu2+77.96 ± 3.2
PSTyr(M374T)-Cu2+35.89 ± 0.3
PSTyr(M374K)-Cu2+23.85 ± 0.5
PSTyr(M374R)-Cu2+18.74 ± 0.7
The measured specific activity of the different tyrosinase variants by MBTH assay. Catecholase activity of each variant was measured three times, and the mean value of measurements was used.

5. Discussion

In the present study, we achieved a tyrosinase mutant with significantly higher catecholase activity. This is the first study that uses site-directed mutagenesis in order to enhance catalytic activity of the human tyrossinase by targeting M374. In all type 3 copper proteins, two CuB alpha helixes are connected by a loop (connector loop). The loop also extends to the vicinity of the first CuA alpha helix and seems to be essential for the active site architecture (Fig. 5a). M374 and V377 are the most conserved residues in the loop. It has been suggested that the peptide bond oxygen atoms of these residues serve as hydrogen bond acceptors for the imidazole NH-groups of the two of the copper binding histidines. Therefore, these two hydrogen bonds stabilize active site architecture ( 29 ). The presence of V377 is limited to some tyrosinase species, and this residue does not exist in the other type-3 copper proteins. Moreover V205, which is the homologous residue of V377 in Streptomyces castaneoglobisporus tyrosinase, is not in the correct orientation to form a hydrogen bond with H38. Unexpectedly, two mutants created by substitution of V218 (homologous residue of V377) in Bacillus megaterium (V218G, and V218F) have exhibited higher catecholase activity in comparison to the wild-type enzyme ( 29 ). These observations have challenged the importance of V377 in the active site architecture. In contrast to V377, all resolved type 3 copper proteins possess a methionine residue at the same location as M374. This residue is densely packed within the surrounding protein matrix, and its side chain extends into the space between two CuB alpha helixes (Fig. 5a). Interestingly, substitution of this methionine residue with a glycine has completely abolished the enzyme activity ( 30 )
Figure 5

Predicted structure of different tyrosinase variants. All figures demonstrate two CuB alpha helixes along with the connector loop. (A) In PSTyr-Cu2+, M374 forms a hydrogen bond with H367 through peptide bond oxygen. (B) In M374D-PSTyr-Cu2+, both carboxyl oxygen atoms form a hydrogen bond with δ-nitrogen of H367. Unlike PSTyr-Cu2+, peptide oxygen of D374 forms a hydrogen bond with the side chain of S380. (C) In M374T-PSTyr-Cu2+, a hydrogen bond is formed between peptide bond oxygen of T374 and δ-nitrogen of H367. Another hydrogen bond is formed between T374 and D383. (D) In M374K-PSTyr-Cu2+, peptide bond oxygen of K374 forms a hydrogen bond with δ-nitrogen of H367. Another hydrogen bond is also possible between side chain nitrogen of K374 and imidazole ring of H389. However, in our model imidazole ring of H389 is not in the correct orientation (E) In M374R-PSTyr-Cu2+, peptide oxygen of R374 forms a hydrogen bond with δ-nitrogen of H367. Also, side chain guanidinium group of R374 forms two additional hydrogen bonds with δ-nitrogen of H389 and side chain carboxyl group of D383.

Predicted structure of different tyrosinase variants. All figures demonstrate two CuB alpha helixes along with the connector loop. (A) In PSTyr-Cu2+, M374 forms a hydrogen bond with H367 through peptide bond oxygen. (B) In M374D-PSTyr-Cu2+, both carboxyl oxygen atoms form a hydrogen bond with δ-nitrogen of H367. Unlike PSTyr-Cu2+, peptide oxygen of D374 forms a hydrogen bond with the side chain of S380. (C) In M374T-PSTyr-Cu2+, a hydrogen bond is formed between peptide bond oxygen of T374 and δ-nitrogen of H367. Another hydrogen bond is formed between T374 and D383. (D) In M374K-PSTyr-Cu2+, peptide bond oxygen of K374 forms a hydrogen bond with δ-nitrogen of H367. Another hydrogen bond is also possible between side chain nitrogen of K374 and imidazole ring of H389. However, in our model imidazole ring of H389 is not in the correct orientation (E) In M374R-PSTyr-Cu2+, peptide oxygen of R374 forms a hydrogen bond with δ-nitrogen of H367. Also, side chain guanidinium group of R374 forms two additional hydrogen bonds with δ-nitrogen of H389 and side chain carboxyl group of D383. In the M374D-PSTyr-Cu2+, both side chain carboxylate oxygen atoms of D374 are in the correct orientation regarding δ-nitrogen of H367 to form a hydrogen bond. In the wild-type tyrosinase, the peptide oxygen atom of M374 is responsible for hydrogen bonding with H367. This change in the pattern of hydrogen bonding can reorient the Cu2O2 complex which in turn increases the possibility of the catecholase reaction. Moreover, the distance between H367 and the connector loop is larger in comparison to that of the wild-type tyrosinase (Fig. 5a, 5b) which exposes the active site to the substrate. Further, peptide bond oxygen of D374 tends to form a hydrogen bond with S380, which results in conformational changes of connector loop. In contrast to M374D-PSTyr-Cu2+, mutated residues in the three other mutational variants form a hydrogen bond with H367 through their peptide oxygen atom similarly to wild-type tyrosinase (Fig. 5c, 5d, and 5e). In M374D-PSTyr-Cu2+, there is another hydrogen bond between the side chain hydroxyl group of T374 and the side chain carboxyl group of D383 (Fig. 5c). Since D383 is on the connector loop, this substitution alters the conformation of two CuB alpha helixes. The resulting conformational change indirectly influences the orientation of Cu2O2 complex. Vital role of the connector loop in the orientation of Cu2O2 complex has been previously reported ( 29 ). In M374K-PSTyr-Cu2+, the second hydrogen bond is formed between the side chain of K374 and H389 (Fig. 5d), which is an essential residue for the correct orientation of the substrate toward Cu2O2 complex ( 31 ). In this mutant, the imidazole ring of H389 is not in the right orientation to form the mentioned hydrogen bond in our model. As the Lysine possesses larger side chain in comparison to methionine, it enters the space between two CuB alpha helices. This can cause a conformational change and influence the orientation of Cu2O2 complex. M374R-PSTyr-Cu2+ exhibited very close results to PSTyr-Cu2+ (Fig. 5e). In addition to the mentioned hydrogen bonding between peptide oxygen of R374 and H367, there are at least two other hydrogen bonds: guanidinium group of R374 and δ-nitrogen of H389, and guanidinium group of R374 and the side chain carboxyl group of D383. The side chain of R374 seems to be involved in the formation of the largest number of hydrogen bonds among all the mutational variants. Despite this prediction, specific activity measurements showed that there is not a significant difference in catecholase activity between M374R-PSTyr-Cu2+ and PSTyr-Cu2+. In the previous studies ( 32 , 33 ), cloning the coding sequence of human tyrosinase resulted in the formation of mainly inclusion bodies. On the contrary, our recombinant enzyme was obtained in soluble form. In addition, wild-type recombinant protein which is produced in our research possesses remarkable catecholase activity compared to the previous studies where only the small soluble fraction exhibited remarkable catecholase activity. Further, this is the first report of mutagenesis of M374 which resulted in tyrosinase variant with higher catecholase activity. Recently, another research has obtained recombinant human tyrosinase from insect cells ( 34 ). Unfortunately, as the activity is not reported as specific activity, it is not comparable to our work.

5.1. Effects of Glycosylation and Phosphorylation

M374 is located after a conserved 371NGT373 glycosylation sequon ( 35 , 36 ). It has been reported that presence of N-glycans at N337 and N371 is required for proper folding of tyrosinaseand the absence of N-glycans at N86, N111 and N161 resulted in temperature-sensitive mutants ( 37 ). Another report states that the absence of N-glycosylation at N86, N230, N337 and N371 abolishes tyrosinase activity ( 38 ). Similarly, inhibition of glycosylation by tunicamycin exerts a similar effect ( 39 , 40 ). More interestingly, N371K is one of the mutations causing oculocutaneous albinism IA ( 41 ). On the other hand, it has been demonstrated that PKC-β is involved in phosphorylation of melanosomal tyrosinase and this enhances protein activity ( 42 , 43 ). It is important to note that all natural modifications occurring on nascent human tyrosinase, ultimately influence the orientation of Cu2O2 complex. That’s why two studies ( 32 , 33 ) conducted previously in parallel with our study have successfully produced the active protein in E. coli. At a glance, these reports look confusing, but it is possible to offer multiple explanations for these controversial observations. As it is more difficult to extract considerable amount of any desired protein from eukaryotes, activity measurements in the previous studies have been reported as relative activities rather than specific activities. We suggest that the specific activity of the wild-type tyrosinase which is obtained from eukaryotic hosts should be much higher than the recombinant protein that is obtained from E. coli cells due to the presence of the perfect post-translational modifications in eukaryotic cells. However, higher amount of the recombinant enzymes obtained from E. coli enables measuring the catecholase activity. In addition, glycans act as quality labels during the maturation of the proteins in eukaryotic cells. It can be suggested that the lack of glycosylation at N371 in tyrosinase leads to ER retention and degradation of tyrosinase by cell proteasome ( 44 ) and subsequently the loss of tyrosinase activity. Finally, as glycosylation can influence the orientation of Cu2O2 complex, mutations with higher catalitic activity must have possessed better oriented Cu2O2 complex.

6. Conclusion

The present research has focused on the production of soluble recombinant tyrosinase in E. coli. Two unique strategies were considered, removal of Clˉ ions and addition of copper ions, to enhance the activity of obtained recombinant wild-type tyrosinase. The addition of copper ions to the wash buffer effectively increased catecholase activity without leaving any adverse effect on Ni-NTA resins. Furthermore, site-directed mutagenesis was applied to achieve mutants with enhanced catecholase activity. Although all mutants possessed higher activity in comparison to the wild-type enzyme, one of the mutants exhibited a substantial increase in the catecholase activity. Obtained tyrosinases are suitable for application in different fields such as agriculture, industry, and medicine.
  42 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  The cotranslational maturation of the type I membrane glycoprotein tyrosinase: the heat shock protein 70 system hands off to the lectin-based chaperone system.

Authors:  Ning Wang; Robert Daniels; Daniel N Hebert
Journal:  Mol Biol Cell       Date:  2005-06-15       Impact factor: 4.138

3.  A new type of uncompetitive inhibition of tyrosinase induced by Cl- binding.

Authors:  Yong-Doo Park; So-Yeon Kim; You-Jeong Lyou; Jin-Young Lee; Jun-Mo Yang
Journal:  Biochimie       Date:  2005-11       Impact factor: 4.079

4.  Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism.

Authors:  R Halaban; S Svedine; E Cheng; Y Smicun; R Aron; D N Hebert
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 5.  Vitiligo: a review of the published work.

Authors:  Reza Yaghoobi; Mohammad Omidian; Nooshin Bagherani
Journal:  J Dermatol       Date:  2011-05       Impact factor: 4.005

6.  New assays for the tyrosine hydroxylase and dopa oxidase activities of tyrosinase.

Authors:  A J Winder; H Harris
Journal:  Eur J Biochem       Date:  1991-06-01

7.  Effect of Cl- on tyrosinase: complex inhibition kinetics and biochemical implication.

Authors:  Hon-Yan Han; Jae-Rin Lee; Wei-An Xu; Myong-Joon Hahn; Jun-Mo Yang; Yong-Doo Park
Journal:  J Biomol Struct Dyn       Date:  2007-10

8.  PROSESS: a protein structure evaluation suite and server.

Authors:  Mark Berjanskii; Yongjie Liang; Jianjun Zhou; Peter Tang; Paul Stothard; You Zhou; Joseph Cruz; Cam MacDonell; Guohui Lin; Paul Lu; David S Wishart
Journal:  Nucleic Acids Res       Date:  2010-05-11       Impact factor: 16.971

9.  Genome-wide association study identifies three loci associated with melanoma risk.

Authors:  D Timothy Bishop; Florence Demenais; Mark M Iles; Mark Harland; John C Taylor; Eve Corda; Juliette Randerson-Moor; Joanne F Aitken; Marie-Francoise Avril; Esther Azizi; Bert Bakker; Giovanna Bianchi-Scarrà; Brigitte Bressac-de Paillerets; Donato Calista; Lisa A Cannon-Albright; Thomas Chin-A-Woeng; Tadeusz Debniak; Gilli Galore-Haskel; Paola Ghiorzo; Ivo Gut; Johan Hansson; Marko Hocevar; Veronica Höiom; John L Hopper; Christian Ingvar; Peter A Kanetsky; Richard F Kefford; Maria Teresa Landi; Julie Lang; Jan Lubiński; Rona Mackie; Josep Malvehy; Graham J Mann; Nicholas G Martin; Grant W Montgomery; Frans A van Nieuwpoort; Srdjan Novakovic; Håkan Olsson; Susana Puig; Marjan Weiss; Wilbert van Workum; Diana Zelenika; Kevin M Brown; Alisa M Goldstein; Elizabeth M Gillanders; Anne Boland; Pilar Galan; David E Elder; Nelleke A Gruis; Nicholas K Hayward; G Mark Lathrop; Jennifer H Barrett; Julia A Newton Bishop
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

10.  Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.

Authors:  R Gershoni-Baruch; A Rosenmann; S Droetto; S Holmes; R K Tripathi; R A Spritz
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.